Xin Lang Cai Jing·2025-10-31 02:56Group 1 - Key Point 1: As of October 30, 2025, a total of 42 institutional investors disclosed holdings in Kailaiying A-shares, with a total holding of 174 million shares, accounting for 48.14% of Kailaiying's total share capital [1] - Key Point 2: The top ten institutional investors collectively hold 46.97% of Kailaiying's shares, with a decrease of 1.46 percentage points compared to the previous quarter [1] Group 2 - Key Point 1: In the current period, 10 public funds increased their holdings, with a total increase ratio of 0.15%, including major funds like Morgan Stanley Health Industry Mixed A and Southern Medical Health Flexible Allocation Mixed A [2] - Key Point 2: 14 public funds decreased their holdings, with a total decrease ratio of 0.56%, including funds such as Huabao CSI Medical ETF and Southern CSI 500 ETF [2] - Key Point 3: 12 new public funds were disclosed in the current period, including Guangfa Shengjin Mixed A and Huatai-PB Medical Health A [2] - Key Point 4: 493 public funds were not disclosed in the current period, including funds like Fortune Tianhui Growth Mixed (LOF) A/B and Southern CSI 500 ETF [2] Group 3 - Key Point 1: One foreign fund increased its holdings, specifically Hong Kong Central Clearing Limited, with an increase ratio of 0.17% [3] - Key Point 2: One new foreign institution was disclosed, namely ASYMCHEM LABORATORIES, INCORPORATED [3] - Key Point 3: ASYMCHEM LABORATORIES, INCORPORATED was not disclosed in the previous quarter [3]